Some posters are rightly concerned about where future cash can come from. Hopefully non-dilutive.
ADO has only a limited amount of cash left; maybe 3 or 4 quarters? Depending on R&D tax refunds plus grants.
Anyway, a couple of possibilities occurred:
- Possible sales of product/kits to GeneoDx for distribution into China. They signed on as a distributor...better get on with it! Can't sell products you don't have.
- Possibly some sales or royalties from Ellume? We seem to be in Ellume's good-books and they seem to be the most advanced with regard to using ADO products in their POC kits.
The I read the Quarterly today. Have a look at "Image 3". It gives a possible timeline for commercialization of ADO product in batteries. The footnote says the image represents 18 months. For Collaborator #1, who signed on about Aug 6th, 2018, commercial product looks possible after about 12 months. So that would be about August 2019.
For Collaborator #2, who signed on about 30th Nov, 2018, commercial product could emerge after about 15 months, which would be about Feb 2020.
So there are 4 possible income streams if all went swimmingly (which I'm sure it won't)! Any or all of them have the potential to delay or reduce the dreaded capital-raising.
FHC
